DS-1 (drug)
From Self-sufficiency
File:DS-1 structure.png | |
Systematic (IUPAC) name | |
---|---|
4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide | |
Identifiers | |
CAS Number | 372497-52-4 |
PubChem | CID 979735 |
Chemical data | |
Formula | C18H10Br2ClN3OS |
Molar mass | 511.617 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
DS-1 is a drug from the imidazopyridine family which is the first drug developed that acts as a GABAA receptor agonist selective for the α4β3δ subtype, which is not targeted by other GABA agonists such as the benzodiazepines or other nonbenzodiazepine drugs. Novel selective drugs such as DS-1 should prove useful in the study of this receptor subtype.[1]
This pharmacology-related article is a stub. You can help ssf by expanding it. |
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
- ↑ Wafford KA, van Niel MB, Ma QP, Horridge E, Herd MB, Peden DR, Belelli D, Lambert JJ. Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus. Neuropharmacology. 2009 Jan;56(1):182-9. PMID 18762200
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Imidazopyridines
- Organobromides
- Organochlorides
- Thiophenes
- Benzamides
- 2Fix